Curaleaf Joins FTSE Canada All Cap Index, Expanding Institutional Reach

  • Curaleaf added to FTSE Canada All Cap Index effective September 18, 2026.
  • Second major Canadian benchmark inclusion after S&P/TSX Composite Index addition in 2025.
  • FTSE Canada All Cap Index tracks large-, mid-, and small-cap Canadian-listed companies.
  • Curaleaf is the first U.S.-based cannabis operator in both major Canadian indices.

Curaleaf's inclusion in two major Canadian indices signals growing institutional acceptance of U.S. cannabis operators. This follows a trend of cross-border market integration, particularly as Canadian indices become proxies for global cannabis exposure. The move could accelerate as more U.S. operators meet listing requirements, potentially reshaping the investment landscape for the sector.

Institutional Adoption
How the index inclusion will affect passive fund allocations to Curaleaf shares.
Liquidity Impact
Whether increased visibility will translate to higher trading volumes and tighter bid-ask spreads.
Regulatory Alignment
The pace at which U.S. cannabis operators gain broader market acceptance through Canadian indices.